首页> 美国卫生研究院文献>Journal of Breast Cancer >BRIP1/FANCJ Mutation Analysis in a Family with History of Male and Female Breast Cancer in India
【2h】

BRIP1/FANCJ Mutation Analysis in a Family with History of Male and Female Breast Cancer in India

机译:印度有男性和女性乳腺癌病史的家庭中的BRIP1 / FANCJ突变分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Male breast cancer (MBC) is a rare and poorly studied disease that is a growing global health problem. Interestingly, both the molecular basis of MBC and its histological profile are often quite distinct from the far more prevalent female breast cancer, emphasizing the need for increased focus on MBC. Here, we present a case report of an MBC patient from India with a strong familial history of breast cancer. This patient was normal for BRCA1/2 and many other common breast cancer-associated genes. However, upon further analysis, the individual was found to possess two mutations in the DNA helicase and tumor suppressor gene BRIP1, including a silent mutation at residue 879 as well as a P919S variant. Other family members were also screened for these mutations. To the best of our knowledge, this is the first report of BRIP1 mutation in MBC in the Indian population.
机译:男性乳腺癌(MBC)是一种罕见且研究不足的疾病,它是一个日益严重的全球健康问题。有趣的是,MBC的分子基础及其组织学特征通常与更为普遍的女性乳腺癌截然不同,从而强调了对MBC的更多关注。在这里,我们介绍了一名来自印度的MBC患者,该患者具有很强的乳腺癌家族史。该患者的BRCA1 / 2和许多其他常见的乳腺癌相关基因正常。然而,经进一步分析,发现该个体在DNA解旋酶和肿瘤抑制基因BRIP1中具有两个突变,包括残基879的沉默突变以及P919S变体。还筛选了其他家庭成员的这些突变。据我们所知,这是印度人口中MBC中BRIP1突变的第一个报道。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号